• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

参与社区临床肿瘤项目的乳腺癌预防试验的应计情况:面板数据分析

Accrual to the Breast Cancer Prevention Trial by participating Community Clinical Oncology Programs: a panel data analysis.

作者信息

Klabunde C N, Kaluzny A D

机构信息

Lineberger Comprehensive Cancer Center, Cecil G. Sheps Center for Health Services Research, University of North Carolina at Chapel Hill 27514, USA.

出版信息

Breast Cancer Res Treat. 1995 Jul;35(1):43-50. doi: 10.1007/BF00694744.

DOI:10.1007/BF00694744
PMID:7612903
Abstract

In 1992 patient accrual to the National Cancer Institute-sponsored Breast Cancer Prevention Trial was initiated in the United States and Canada. The Trial will involve 16,000 women who are evaluated to be at high risk of developing breast cancer. Nearly 250 health care organizations are participating in the Trial, including over 40 Community Clinical Oncology Program (CCOP) organizations, which are a component of the NCI's national clinical trials program. A previous NCI-funded evaluation conducted by the University of North Carolina showed the CCOP program to be an effective means of transferring the latest cancer technology, particularly cancer treatments, to the community setting. This paper describes a study designed to evaluate the performance of CCOP organizations in the Breast Cancer Prevention Trial. Using data from the first fifteen months of the Trial, the ability of CCOPs to accrue women is assessed using panel data estimation techniques. An attempt is made to predict accrual by structural, process, and environmental characteristics of participating CCOPs. Factors predictive of accrual include month in which accrual occurred and the extent of competition for trial participants in the CCOP service area. The hypothesized model explains slightly over 19 percent of the variation in accrual performance. The analysis demonstrates the utility of a panel data approach to modeling the dynamics of CCOP participation in a chemoprevention clinical trial.

摘要

1992年,美国和加拿大开始了由美国国立癌症研究所资助的乳腺癌预防试验的患者招募工作。该试验将涉及16000名被评估为患乳腺癌高危的女性。近250个医疗保健组织参与了该试验,其中包括40多个社区临床肿瘤项目(CCOP)组织,这些组织是国立癌症研究所国家临床试验项目的一部分。北卡罗来纳大学此前进行的一项由国立癌症研究所资助的评估表明,CCOP项目是将最新癌症技术,尤其是癌症治疗方法,推广到社区环境的有效手段。本文描述了一项旨在评估CCOP组织在乳腺癌预防试验中表现的研究。利用该试验前十五个月的数据,使用面板数据估计技术评估CCOP招募女性的能力。试图通过参与试验的CCOP的结构、过程和环境特征来预测招募情况。预测招募的因素包括招募发生的月份以及CCOP服务区域内试验参与者的竞争程度。假设模型解释了招募表现中略多于19%的变异。分析表明,面板数据方法在模拟CCOP参与化学预防临床试验的动态过程中具有实用性。

相似文献

1
Accrual to the Breast Cancer Prevention Trial by participating Community Clinical Oncology Programs: a panel data analysis.参与社区临床肿瘤项目的乳腺癌预防试验的应计情况:面板数据分析
Breast Cancer Res Treat. 1995 Jul;35(1):43-50. doi: 10.1007/BF00694744.
2
Performance in quasi-firms: an example from the Community Clinical Oncology Program.准企业中的表现:以社区临床肿瘤项目为例。
J Health Hum Resour Adm. 1992 Winter;14(3):307-26.
3
Community Clinical Oncology Program participation in the Breast Cancer Prevention Trial: factors affecting accrual.社区临床肿瘤项目参与乳腺癌预防试验:影响病例数增加的因素
Cancer Epidemiol Biomarkers Prev. 1995 Oct-Nov;4(7):783-9.
4
Predicting the performance of a strategic alliance: an analysis of the Community Clinical Oncology Program.预测战略联盟的绩效:社区临床肿瘤项目分析
Health Serv Res. 1993 Jun;28(2):159-82.
5
Sustainability and performance of the National Cancer Institute's Community Clinical Oncology Program.国家癌症研究所社区临床肿瘤学计划的可持续性和绩效。
Contemp Clin Trials. 2012 Jan;33(1):46-54. doi: 10.1016/j.cct.2011.09.007. Epub 2011 Oct 2.
6
Accrual to National Cancer Institute-sponsored non-small-cell lung cancer trials: insights and contributions from the CCOP program. accrual 至国家癌症研究所赞助的非小细胞肺癌试验:来自 CCOP 计划的见解和贡献。
Clin Lung Cancer. 2009 Nov;10(6):410-3. doi: 10.3816/CLC.2009.n.077.
7
Evaluating organizational design to assure technology transfer: the case of the Community Clinical Oncology Program.评估组织设计以确保技术转移:社区临床肿瘤项目案例
J Natl Cancer Inst. 1989 Nov 15;81(22):1717-25. doi: 10.1093/jnci/81.22.1717.
8
The effects of managed care and competition on community-based clinical research.管理式医疗与竞争对社区临床研究的影响。
Med Care. 2006 Jul;44(7):671-9. doi: 10.1097/01.mlr.0000220269.65196.72.
9
Assuring access to state-of-the-art care for U.S. minority populations: the first 2 years of the Minority-Based Community Clinical Oncology Program.确保美国少数族裔人群能够获得最先进的医疗服务:基于少数族裔的社区临床肿瘤项目的头两年。
J Natl Cancer Inst. 1993 Dec 1;85(23):1945-50. doi: 10.1093/jnci/85.23.1945.
10
Clinical trials in the community. The community clinical oncology program experience.社区中的临床试验。社区临床肿瘤学项目经验。
Cancer. 1994 Nov 1;74(9 Suppl):2694-700. doi: 10.1002/1097-0142(19941101)74:9+<2694::aid-cncr2820741819>3.0.co;2-d.

引用本文的文献

1
Cancer patient decision making related to clinical trial participation: an integrative review with implications for patients' relational autonomy.癌症患者参与临床试验的决策制定:一项对患者关系自主性有影响的综合综述
Support Care Cancer. 2015 Apr;23(4):1169-96. doi: 10.1007/s00520-014-2581-9. Epub 2015 Jan 17.
2
Recruiting low-income healthy women to research: an exploratory study.招募低收入健康女性参与研究:一项探索性研究。
Ethn Health. 2007 Nov;12(5):497-519. doi: 10.1080/13557850701616961.

本文引用的文献

1
Predicting the performance of a strategic alliance: an analysis of the Community Clinical Oncology Program.预测战略联盟的绩效:社区临床肿瘤项目分析
Health Serv Res. 1993 Jun;28(2):159-82.
2
Accrual of patients to randomized clinical trials. Factors affecting cancer prevention and control research.
Int J Technol Assess Health Care. 1994 Summer;10(3):506-16. doi: 10.1017/s0266462300006723.
3
Cancer prevention and control: from research through applications.癌症预防与控制:从研究到应用
J Natl Cancer Inst. 1987 Aug;79(2):389-400.
4
Evaluating organizational design to assure technology transfer: the case of the Community Clinical Oncology Program.评估组织设计以确保技术转移:社区临床肿瘤项目案例
J Natl Cancer Inst. 1989 Nov 15;81(22):1717-25. doi: 10.1093/jnci/81.22.1717.
5
Clinical cancer research in Louisiana.
J La State Med Soc. 1991 Apr;143(4):27-9.
6
Antiestrogen chemoprevention of breast cancer: critical issues and research.
Prev Med. 1991 Jan;20(1):64-78. doi: 10.1016/0091-7435(91)90007-q.
7
NIH fends off critics of tamoxifen study.
Science. 1992 Oct 30;258(5083):734. doi: 10.1126/science.1439776.